Advertisement

SYK

Stryker Corporation

Healthcare · USD

Set alert

Price alert · SYK

All alert types
291.86 USD -19.89 -6.38%
As of Oct 30, 2026 Extended hours 293.00 +0.39%
Bid
290.67 × 80
Ask
291.82 × 200
282.18 Day range 299.17
269.75 52-week range 387.46
YTD
-16.96%
1 year
-20.90%
Open
287.97
Prev close
311.75
Mkt cap
111.95B
Vol
6.44M
Avg vol
2.66M
EPS
9.65
P/E
30.24
Div yield
1.13%
More statistics
Low
282.18
High
299.17
Forward P/E
17.51
Beta
0.78
Short ratio
2.15
Inst. own
83.40%
Dividend
3.52
Ex-div date
Sep 29, 2026
Earnings
Feb 4, 2027
50-d avg
293.42
200-d avg
324.16
1y target
362.62

5D chart

Chart tools
Interval
SYK five-day price chart282.2289.8297.5305.1312.8Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
111.84B
Enterprise value
131.55B
Trailing P/E
30.22
Forward P/E
17.51
PEG ratio
1.46
Price / sales
4.33
Price / book
4.66
EPS (TTM)
9.65
Beta
0.78
Dividend yield
1.13%
Payout ratio
36.06%
Profit margin
14.43%
Revenue (TTM)
25.84B
Revenue growth
9.40%
Free cash flow
4.11B
Total cash
3.48B
Total debt
15.45B
Return on equity
16.51%
Shares outstanding
383.57M
Short % of float
1.55%
50-day average
293.42
200-day average
324.16

Analyst view

Consensus: buy

Buy
Price target (mean) 362.62 +24.2% upside
Target (low)
298.00
Target (mean)
362.62
Target (high)
465.00
Ratings (0m) 30 23 buy · 7 hold · 0 sell
  • Strong buy8
  • Buy15
  • Hold7
  • Sell0
  • Strong sell0

Next earnings

Feb 4, 2027

Expected Feb 4, 2027. Consensus EPS estimate 5.09.

Earnings history

Financials — quick view

All financials
SYK Revenue — quarterly 6.59B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SYK Net income — quarterly 1.28B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SYK EPS — quarterly 3.32
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

SYK recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 4, 2027Dec 30, 20265.07———
Oct 29, 2026Sep 30, 20263.553.52-0.03-0.85%
Jul 30, 2026Jun 30, 20263.493.69+0.20+5.73%
Apr 30, 2026Mar 31, 20262.982.60-0.38-12.75%
Jan 29, 2026Dec 31, 20254.404.47+0.07+1.59%
Oct 30, 2025Sep 30, 20253.133.19+0.06+1.92%

Upgrades / downgrades

SYK analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026RBC CapitalmainOutperformOutperform
Oct 30, 2026BarclaysmainOverweightOverweight
Oct 30, 2026Canaccord GenuitydownBuyHold
Oct 30, 2026CitizensmainMarket OutperformMarket Outperform
Oct 30, 2026Evercore ISI GroupmainOutperformOutperform
Oct 30, 2026NeedhammainBuyBuy

About Stryker Corporation

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
stryker.com

News

Your note

Sign in to keep a note on SYK — it syncs with the Stock Master app.

Insider holders

SYK insider holders
InsiderRelationLatest transactionDateShares held
BECKER YIN COfficerConversion of Exercise of derivative securityMar 20, 202536,052
CROTTY DYLAN BRAMOfficerSaleAug 20, 20260
FINK MARY KATHRYNOfficerSaleMay 10, 20260
GOLSTON ALLAN CDirectorSaleFeb 17, 202514,895
LOBO KEVIN AChief Executive OfficerConversion of Exercise of derivative securityMar 19, 2026222,952
MENON VIJU SOfficerConversion of Exercise of derivative securityMar 19, 202617,580

Institution ownership

SYK institution ownership
Holder% heldSharesValueReported
Blackrock Inc.7.15%27,414,7427.99BJun 29, 2026
Vanguard Capital Management LLC5.88%22,536,8436.57BJun 29, 2026
JPMORGAN CHASE & CO4.50%17,260,9435.03BJun 29, 2026
State Street Corporation4.05%15,532,5654.53BJun 29, 2026
Greenleaf Trust3.95%15,155,9334.42BSep 29, 2026
Price (T.Rowe) Associates Inc3.11%11,916,0573.47BJun 29, 2026

Fund ownership

SYK fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.86%10,952,9793.19BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.33%8,941,9262.61BJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.21%4,650,7411.36BSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.17%4,478,7341.31BAug 30, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.13%4,318,8411.26BSep 29, 2026
SELECT SECTOR SPDR TRT-State Street Health Care Select Sector SPDR ETF0.64%2,469,410720.04MSep 29, 2026
Advertisement